全血球計數器市場規模、佔有率和成長分析：按產品類型、模式、應用、最終用戶、技術、處理能力和地區分類－2026-2033年產業預測

2024 年全球全血球計數 (CBC) 設備市場價值為 46 億美元，預計到 2025 年將成長至 49.8 億美元，到 2033 年將成長至 93.5 億美元，預測期（2026-2033 年）複合年成長率為 8.2%。

全球全血球計數 (CBC) 設備市場正經歷顯著成長，這主要得益於感染疾病、貧血和慢性疾病發病率的上升，這些疾病需要定期進行血液學評估。人們對預防性醫療保健的意識增強和需求增加，也推動了醫院、診斷檢查室和診所 CBC 檢測量的激增。自動化血液檢測系統和人工智慧數據分析等技術創新提高了檢測準確性並簡化了工作流程。此外，新興市場醫療基礎設施的不斷改善以及政府對診斷服務的投資也促進了市場擴張。全球人口老化和對快速診斷日益成長的需求也推動了對可靠、高容量 CBC 設備的需求。人工智慧技術的進步提高了分析準確性和營運效率，進一步鞏固了市場的強勁表現。

全球全血球計數 (CBC) 設備市場按產品類型、檢測方式、應用領域、最終用戶、技術、容量和地區進行細分。依產品類型分類，市場分為三分類分類血液分析儀、五分類分類血液分析儀、即時檢測 (POC) CBC 設備和全自動 CBC 分析儀。依檢測方法分類，市場分為桌上型 CBC 設備和攜帶式CBC 設備。按應用領域分類，市場分為常規血液檢測、疾病診斷和監測、術前檢測、急診和重症監護檢測以及其他。按最終用戶分類，市場分為醫院、診斷檢查室、診所、學術和研究機構以及其他。依技術分類，市場分為電阻分析儀、流式細胞技術分析儀和混合技術分析儀。依容量分類，市場分為低容量、中容量和高容量。依地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球全血球計數器市場的成長要素

醫療專業人員日益重視血液疾病的早期檢測，推動了全血球計數器的需求成長。這些創新設備能夠快速且準確地評估各種細胞參數，對於有效的常規篩檢和風險評估至關重要。隨著預防仍然是重點，診所和醫院正在加速將這些設備整合到標準流程中，導致市場需求穩定成長。隨著臨床重點轉向持續監測和及時干預，這一趨勢為市場參與企業帶來了許多機會。因此，這種對預防性護理的重視正在推動全球不同醫療機構的強勁成長。

全球血液常規檢查設備市場的限制因素

全球全血球計數 (WCR) 市場面臨許多限制因素，包括由於其對先進硬體和軟體組件的依賴而產生的大量前期投資。這種財務負擔可能構成重大挑戰，尤其是在小規模的診所和新興市場。由於預算有限，這些市場可能被迫選擇功能較弱但成本效益較高的設備。因此，這些先進診斷工具的高成本可能會阻礙其廣泛應用並減緩市場成長。應對財務限制的壓力最終限制了高性能技術的應用，從而影響各個地區的整體市場發展。

全球全血計數設備市場趨勢

全球全血球計數 (WCR) 市場正呈現出向人工智慧驅動的診斷自動化整合的顯著趨勢。醫療服務提供者正擴大將先進演算法整合到 WCR 分析儀中，以加快結果解讀並最大限度地減少人為錯誤。這種轉變增強了即時數據分析能力，使臨床醫生能夠快速獲得可操作的見解並簡化治療決策。此外，這種自動化還支援遠端監控功能，使檢查室即使在人員有限的情況下也能保持強大的處理能力。隨著機器學習模式的發展，健康預測能力不斷提升，從而促進了預防醫學的發展，那些能夠無縫整合人工智慧的供應商正在成為全球市場的領導者。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 宏觀經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 疾病流行病學

全球全血球計數器市場規模：依產品類型分類

• 3 分類血液分析儀
• 5 分類血液分析儀
• 用於床邊檢測的血球計數測量設備
• 全自動血球計數分析儀

全球全血球計數器市場規模：依模式分類

• 桌上型CBC設備
• 攜帶式CBC設備

全球全血球計數器市場規模：按應用領域分類

• 常規血液檢查
• 疾病診斷與監測
• 術前檢查
• 急診和重症監護檢查
• 其他

全球全血球計數器市場規模：依最終用戶分類

• 醫院
• 診斷檢查室
• 診所
• 學術研究機構
• 其他

全球全血球計數器市場規模：依技術分類

• 電阻式分析儀
• 流式細胞技術儀
• 混合技術分析儀器

全球全血球計數器市場規模：依處理能力分類

• 低吞吐量
• 中等吞吐量
• 高通量

全球全血球計數器市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Sysmex Corporation
• Danaher Corporation
• Abbott Laboratories
• Siemens Healthineers AG
• HORIBA, Ltd.
• Mindray Medical International Limited
• Nihon Kohden Corporation
• Boule Diagnostics AB
• Diatron MI Zrt.
• ERBA Diagnostics Mannheim GmbH
• Shenzhen Dymind Biotechnology Co., Ltd.
• DIRUI Industrial Co., Ltd.
• Rayto Life and Analytical Sciences Co., Ltd.
• Drawell International Technology Co., Ltd.
• URIT Medical Electronic Co., Ltd.
• Orphee SA
• Analyticon Biotechnologies GmbH
• EKF Diagnostics Holdings plc
• Diesse Diagnostica Senese SpA
• Agappe Diagnostics Ltd.

結論與建議

Global Complete Blood Count Device Market size was valued at USD 4.6 Billion in 2024 and is poised to grow from USD 4.98 Billion in 2025 to USD 9.35 Billion by 2033, growing at a CAGR of 8.2% during the forecast period (2026-2033).

The global Complete Blood Count (CBC) device market is experiencing significant growth driven by the rising incidence of infectious diseases, anemia, and chronic conditions requiring regular hematological assessments. Increased awareness and preference for preventive healthcare are contributing to a surge in CBC testing across hospitals, diagnostic labs, and physician offices. Innovations such as automated hematology analyzers and AI-assisted data interpretation are enhancing accuracy and streamlining workflows. Furthermore, expanding healthcare infrastructure in emerging markets and government investments in diagnostic services bolster market expansion. The aging global population and rising demand for rapid diagnostics also fuel the need for reliable, high-throughput CBC testing devices. AI advancements are refining analytical accuracy and operational efficiency, further solidifying the market's positive trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Complete Blood Count Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Complete Blood Count Device Market Segments Analysis

The global complete blood count device market is segmented by product type, modality, application, end user, technology, throughput and region. Based on product type, the market is segmented into 3-Part Differential Hematology Analyzers, 5-Part Differential Hematology Analyzers, Point-Of-Care Cbc Devices and Fully Automated Cbc Analyzers. Based on modality, the market is segmented into Benchtop Cbc Devices and Portable Cbc Devices. Based on application, the market is segmented into Routine Hematology Testing, Disease Diagnosis & Monitoring, Preoperative Testing, Emergency & Critical Care Testing and Others. Based on end user, the market is segmented into Hospitals, Diagnostic Laboratories, Physician Offices, Academic & Research Institutes and Others. Based on technology, the market is segmented into Impedance-Based Analyzers, Flow Cytometry-Based Analyzers and Hybrid Technology Analyzers. Based on throughput, the market is segmented into Low Throughput, Medium Throughput and High Throughput. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Complete Blood Count Device Market

The growing emphasis on the early detection of hematologic disorders by healthcare providers is driving the demand for comprehensive blood count devices. These innovative instruments enable rapid and accurate assessment of various cell parameters, which is essential for effective routine screening and risk evaluation. As prevention remains a key focus, clinics and hospitals are increasingly integrating these devices into their standard procedures, resulting in consistent demand. This trend opens up numerous opportunities for market participants, as clinical priorities shift towards continuous monitoring and timely interventions. Consequently, this focus on proactive care fuels robust growth across diverse healthcare settings on a global scale.

Restraints in the Global Complete Blood Count Device Market

The Global Complete Blood Count Device market encounters significant limitations due to the reliance on sophisticated hardware and software components, which necessitate substantial initial investments. This financial burden can be particularly challenging for smaller clinics and emerging markets, where limited budgets may compel decisions that favor more cost-effective, albeit less advanced, equipment options. Consequently, the high costs associated with these advanced diagnostic tools can impede broader deployment, resulting in a more gradual growth trajectory. The pressure to manage financial constraints ultimately restricts the adoption of higher-performance technologies, impacting the market's overall development across various regions.

Market Trends of the Global Complete Blood Count Device Market

The Global Complete Blood Count Device market is witnessing a notable trend towards the integration of AI-driven diagnostic automation. Healthcare providers are increasingly adopting advanced algorithms within complete blood count analyzers to expedite result interpretation and minimize manual errors associated with human oversight. This shift enhances real-time data analytics, enabling clinicians to access actionable insights swiftly, thereby streamlining treatment decisions. Additionally, such automation supports remote monitoring capabilities, allowing laboratories to maintain high throughput even with limited staffing. As machine learning models advance, they provide predictive health trends that bolster preventive care, positioning vendors with seamless AI integration as leaders in the global marketplace.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Disease Epidemiology

Global Complete Blood Count Device Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• 3-Part Differential Hematology Analyzers
• 5-Part Differential Hematology Analyzers
• Point-Of-Care Cbc Devices
• Fully Automated Cbc Analyzers

Global Complete Blood Count Device Market Size by Modality & CAGR (2026-2033)

• Market Overview
• Benchtop Cbc Devices
• Portable Cbc Devices

Global Complete Blood Count Device Market Size by Application & CAGR (2026-2033)

• Market Overview
• Routine Hematology Testing
• Disease Diagnosis & Monitoring
• Preoperative Testing
• Emergency & Critical Care Testing
• Others

Global Complete Blood Count Device Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Physician Offices
• Academic & Research Institutes
• Others

Global Complete Blood Count Device Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Impedance-Based Analyzers
• Flow Cytometry-Based Analyzers
• Hybrid Technology Analyzers

Global Complete Blood Count Device Market Size by Throughput & CAGR (2026-2033)

• Market Overview
• Low Throughput
• Medium Throughput
• High Throughput

Global Complete Blood Count Device Market Size & CAGR (2026-2033)

• North America (Product Type, Modality, Application, End User, Technology, Throughput)
  • US
  • Canada
• Europe (Product Type, Modality, Application, End User, Technology, Throughput)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Modality, Application, End User, Technology, Throughput)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Modality, Application, End User, Technology, Throughput)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Modality, Application, End User, Technology, Throughput)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HORIBA, Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boule Diagnostics AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diatron MI Zrt.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ERBA Diagnostics Mannheim GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Dymind Biotechnology Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DIRUI Industrial Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rayto Life and Analytical Sciences Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drawell International Technology Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• URIT Medical Electronic Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orphee SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Analyticon Biotechnologies GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics Holdings plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diesse Diagnostica Senese S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agappe Diagnostics Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations